Dr. Khvaramze Shaverdashvili, MD, PhD

  • Philadelphia, PA
  • Hematologist and oncologist
NPI1932555182PAC ID3274860473
Medicare services, 2021
39
Part D claims, 2019
219
Publications
12
Hospital affiliations
1
Industry payments
$757
Practice address
833 Chestnut St, Philadelphia, PA 19107
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Jefferson Division of Psychiatry and Human Behavior - HOPD

Childrens Hospital outpatient department · Philadelphia, Pennsylvania

See all 8 affiliations

Find Dr. Shaverdashvili's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Khvaramze Shaverdashvili is a hematologist and oncologist in Philadelphia, Pennsylvania

Dr. Shaverdashvili practices at Jefferson Division of Psychiatry and Human Behavior - HOPD in Philadelphia, Pennsylvania.

Dr. Shaverdashvili's NPI, 1932555182, was assigned on May 6, 2016. Dr. Shaverdashvili holds Pennsylvania license MT223009.

NPI and contact details
Medicare PAC ID
3274860473
NPI enumeration date
May 6, 2016
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
45
Medical school graduation
2007

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Khvaramze Shaverdashvili practices at Jefferson Division of Psychiatry and Human Behavior - HOPD in Philadelphia, Pennsylvania

Dr. Shaverdashvili's primary practice is Jefferson Division of Psychiatry and Human Behavior - HOPD, at 833 Chestnut St, Philadelphia, PA 19107.

  • Jefferson Division of Psychiatry and Human Behavior - HOPD
    833 Chestnut St, Philadelphia, PA 19107

Source: Dmand AI Affiliation Data

Dr. Khvaramze Shaverdashvili is affiliated with 5 sites of care and 3 medical groups

Dr. Shaverdashvili's primary practice is Jefferson Division of Psychiatry and Human Behavior - HOPD in Philadelphia, Pennsylvania. Dr. Shaverdashvili is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Shaverdashvili to 3 more group practices and clinics and 2 medical groups, each named with a free account. Dr. Shaverdashvili's employer is on file too: a hospital.

See all 8 affiliations for Dr. Shaverdashvili

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Khvaramze Shaverdashvili's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shaverdashvili practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Jefferson Division of Psychiatry and Human Behavior - HOPDAvailable with a free account
+4 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Shaverdashvili practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Khvaramze Shaverdashvili is one of 645 hematologists and oncologists in Pennsylvania

Hematology and oncology is Dr. Shaverdashvili's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Shaverdashvili's licenses on file in 2 states: Pennsylvania and New York.

Specialties and state licenses

  • Hematology and oncology, PennsylvaniaPrimaryLicense MT223009 · taxonomy 207RH0003X
  • Student in an organized health care education/training program, New Yorktaxonomy 390200000X

Hematologists and oncologists near Dr. Shaverdashvili

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Khvaramze Shaverdashvili billed Medicare for 39 services in 2021

CMS data shows 39 Medicare services from Dr. Shaverdashvili across 2 procedure codes in 2021. Medicare paid $4,347 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 202139
Paid by Medicare$4,347
Procedure codes2

Dr. Shaverdashvili's Medicare services by type, 2020 to 2021

  • 2020
  • 2021
Office and hospital visits
2020: 1262021: 3969%

Dr. Shaverdashvili compared with the Pennsylvania median for hematologists and oncologists, 2021

  • Dr. Shaverdashvili
  • Pennsylvania median
Medicare services
39vs 65494% below
Part D claims
219vs 39344% below

Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.

Dr. Shaverdashvili's most billed Medicare procedure codes, 2021

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Shaverdashvili

Need commercial claims for Dr. Shaverdashvili?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Shaverdashvili and other hematologists and oncologists in Pennsylvania.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Khvaramze Shaverdashvili's patients have a median age of 64

Across all payers, Dmand AI patient panel data puts Dr. Shaverdashvili's median patient age at 64, with 50% women.

Dr. Shaverdashvili's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 64

Patient panel by sex, all payers

  • Women50%
  • Men48%

Source: Dmand AI Patient Panel Data

Dr. Khvaramze Shaverdashvili wrote 219 Medicare Part D claims in 2019

In 2019, Dr. Shaverdashvili wrote 219 Medicare Part D claims. They cover 11 drugs, with $2,389 in total drug cost. In 2018, CMS named 157 claims across 8 drugs.

Part D claims, 2019219
Drugs named by CMS11
Total drug cost$2,389

Dr. Shaverdashvili's most prescribed drugs by claims, 2019

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2018 to 2019

  • 2018
  • 2019
Claims for drugs CMS names
2018: 1572019: 21939%

Drugs named by CMS: 11 in 2019, 8 in 2018.

See all prescribing by Dr. Shaverdashvili

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

Dr. Khvaramze Shaverdashvili offers telehealth to Medicare patients

Dr. Shaverdashvili accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shaverdashvili as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Shaverdashvili by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Khvaramze Shaverdashvili has 12 publications on record

Dmand AI links 12 papers to Dr. Shaverdashvili, published from 2014 to 2024. 2023 was the busiest year, with 3. The most frequent topics are Cell Line, Tumor, Cell Movement and Matrix Metalloproteinase 14. Dr. Shaverdashvili has published most often in JTO Clin Res Rep. Dr. Shaverdashvili's most frequent co-authors are Jonathan Edwards Dowell, MD, Charu Aggarwal, MD, MPH and Nadeem A. Akbar, MD.

Papers12
Years published2014 to 2024

Dr. Shaverdashvili's papers by year, 2014 to 2024

Topics Dr. Shaverdashvili writes about most

  • Cell Line, Tumor
  • Cell Movement
  • Matrix Metalloproteinase 14
  • Melanoma
  • Neoplasm Invasiveness
  • Carcinoma, Non-Small-Cell Lung
  • Enzyme Activation
  • Lung Neoplasms

Dr. Shaverdashvili's most frequent co-authors

Recent publications by Dr. Shaverdashvili

See all 12 publications and co-authors

See who Dr. Shaverdashvili researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Shaverdashvili works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Khvaramze Shaverdashvili received $757 in industry payments from 2022 to 2025

CMS Open Payments shows 7 general payments to Dr. Shaverdashvili from 4 drug and device companies from 2022 to 2025. Education make up the largest share, 63% of the total. Eli Lilly and Company paid the most, $394.

General payments to Dr. Shaverdashvili by program year, 2022 to 2025

General payments to Dr. Shaverdashvili by kind, 2022 to 2025

$757in total
  • Education$47463%
  • Food and beverage$28337%

Companies that paid Dr. Shaverdashvili the most, 2022 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Shaverdashvili

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Khvaramze Shaverdashvili's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Khvaramze Shaverdashvili

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Khvaramze Shaverdashvili's NPI number?

Dr. Khvaramze Shaverdashvili's NPI number is 1932555182. It was assigned on May 6, 2016, and it is active in the NPI Registry.

What kind of doctor is Dr. Khvaramze Shaverdashvili?

Dr. Khvaramze Shaverdashvili is a hematologist and oncologist in Philadelphia, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Khvaramze Shaverdashvili practice?

Dr. Shaverdashvili practices at 833 Chestnut St, Philadelphia, PA 19107. Dr. Shaverdashvili's primary practice is Jefferson Division of Psychiatry and Human Behavior - HOPD in Philadelphia, Pennsylvania. Dmand AI also links Dr. Shaverdashvili to 3 group practices and clinics and 2 medical groups.

What is Dr. Khvaramze Shaverdashvili's medical license number?

Dr. Shaverdashvili holds Pennsylvania license MT223009, one of the licenses on file in 2 states.

Which states has Dr. Khvaramze Shaverdashvili been licensed in?

Dmand AI has state licenses on file for Dr. Shaverdashvili in Pennsylvania and New York.

Which hospitals is Dr. Khvaramze Shaverdashvili affiliated with?

Dr. Shaverdashvili is affiliated with Thomas Jefferson University Hospital.

What medical group is Dr. Khvaramze Shaverdashvili part of?

Dr. Shaverdashvili is linked to Jefferson University Physicians. Dmand AI links Dr. Shaverdashvili to 2 more medical groups.

Does Dr. Khvaramze Shaverdashvili accept Medicare?

Yes. CMS data shows Dr. Shaverdashvili billed Medicare for 39 services in 2021, and Dr. Shaverdashvili accepts Medicare assignment.

Does Dr. Khvaramze Shaverdashvili offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Shaverdashvili as offering telehealth services.

What services does Dr. Khvaramze Shaverdashvili bill to Medicare?

In 2021, Dr. Shaverdashvili's most billed Medicare services were hospital inpatient care (99233) and hospital inpatient care (99223).

Show 5 more questionsShow fewer questions

What drugs does Dr. Khvaramze Shaverdashvili prescribe most?

In 2019 Medicare Part D data, Dr. Shaverdashvili's most prescribed drugs by claims were Lisinopril, Amlodipine Besylate and Atorvastatin Calcium.

Has Dr. Khvaramze Shaverdashvili received payments from drug or device companies?

CMS Open Payments shows $757 in general payments to Dr. Shaverdashvili from 4 companies from 2022 to 2025. The largest total came from Eli Lilly and Company.

How long has Dr. Khvaramze Shaverdashvili been practicing?

Dr. Shaverdashvili graduated from medical school in 2007, 19 years ago.

Does Dr. Khvaramze Shaverdashvili do research?

Dmand AI links 12 publications to Dr. Shaverdashvili, published from 2014 to 2024.

Who does Dr. Khvaramze Shaverdashvili publish with?

Dr. Shaverdashvili's most frequent co-authors are Jonathan Edwards Dowell, MD (2 shared papers), Charu Aggarwal, MD, MPH (1 shared paper) and Nadeem A. Akbar, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in Pennsylvania by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)